BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190317
DTEND;VALUE=DATE:20190322
DTSTAMP:20260729T212407
CREATED:20180519T165918Z
LAST-MODIFIED:20180519T170059Z
UID:20110-1552780800-1553212799@ces.b2sg.org
SUMMARY:Epigenetics and Human Disease
DESCRIPTION:Epigenetics is a major mechanism in human health and disease. Data from a range of diseases (cancer\, neurological and immunological disorders) have uncovered altered epigenomes arising from mutations\, altered expression and/or copy number alterations of numerous epigenetic factors (histones\, DNA and chromatin modifying enzymes\, reader proteins\, chromatin modulators and noncoding RNAs). Genome-wide analyses have illustrated the relationship between altered epigenetic states (e.g.\, modified DNA\, histones and chromatin packaging) and disease onset and progression. Furthermore\, both local and long-range nuclear chromatin architecture are increasingly recognized as major contributors to normal and pathologic epigenetic states.  \nThis meeting\, held jointly with “3D genome”\, will cover the most current knowledge of epigenetic events modulating nuclear function (gene expression regulation\, enhancer modulation\, domains and structural organization as well as cell division and differentiation)\, while relating this to normal and disease models. In addition\, this meeting will highlight the impact that preclinical and clinical epigenetic therapeutics have on multiple diseases including cancer\, immunology\, and neurological disorders. An interdisciplinary panel of speakers including both thought leaders in the field as well as young investigators will survey the latest research results and conceptual understanding of fundamental mechanisms of epigenetic signaling\, especially as relates to regulation of gene expression programs. Presentations and workshops will highlight the latest technologies and methodologies for studying epigenetic states and 3D chromatin architecture in cells\, tissues and organisms. \n  \nThe meeting will begin on Sunday\, March 17 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday\, March 21 with a closing plenary session from 17:00 to 19:00\, followed by a social hour and entertainment. We recommend return travel on Friday\, March 22 in order to fully experience the meeting.  \n  \nProgram: \n– 3D Epigenome/Epigenetics and Disease \n-Workshop: 4DN Nucleome Consortium Resources \n-Epigenetic Dysregulation in Neurobiology  \n-Single Cell Analysis of Genome Architecture  \n-Understanding and Targeting Epigenetic Dysregulation \n-Analysis of 3D Genome with Advanced Microscopy  \n– Workshop: ENCODE Consortium Resources \n-Infectious Diseases and Autoimmunity  \n-Chromatin and Epigenetics  \n-Chromatin Signaling and Epigenetic Mechanisms \n-3D Genome and Gene Regulation \n-Workshop: International Human Epigenome Consortium  \n-Metabolic Diseases and Aging \n-Genome Architecture and Development \n-Epigenetic Regulation in Immunoncology and Cancer Therapeutics  \n-Computational Analysis of 3D Genome \n-3D Genome and Disease \n  \nDeadlines: \nScholarship Deadline: Nov 15\, 2018 \n Discounted Abstract Deadline: Nov 15\, 2018\n Abstract Deadline: Dec 12\, 2018\n Discounted Registration Deadline: Jan 22\, 2019 \n 
URL:https://ces.b2sg.org/event/keystone-17mar19/
LOCATION:Fairmont Banff Springs\, 405 Spray Avenue\, Banff\, Alberta\, T1L 1J4\, Canada
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/keystone-e1494159273833.jpg
END:VEVENT
END:VCALENDAR